P53诱导细胞凋亡抑制蛋白抗体
Inhibitor of p53 induced apoptosis beta; IPIA beta; NDK-H 5; NDP kinase homolog 5; NM23 H5; Nm23-M5; NM23H5; Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); Nonmetastatic
黑色素瘤相关抗原3抗体
Antigen MZ2 D; Antigen MZ2-D; Cancer/testis antigen 1.3; Cancer/testis antigen family 1 member 3; CT1.3; HIP8; HYPD; MAGA3_HUMAN; MAGE 3 antigen; MAGE-3 antigen; MAGE3; MAGEA3; MAGEA6; Me
磷酸化谷氨酸受体2B抗体
NMDAR2B (Phospho-Tyr1474); NMDAR2B (Phospho-Y1474); p-NMDAR2B (Tyr1474); p-NMDAR2B (Y1474); AW490526; Glutamate [NMDA] receptor subunit epsilon 2; Glutamate [NMDA] receptor subunit epsilon-2; Glutamat
微小染色体维持缺陷蛋白8抗体
C20orf154; dJ967N21.5; DNA helicase MCM8; DNA replication licensing factor MCM8; MCM8; MCM8_HUMAN; MGC119522; MGC119523; MGC12866; MGC4816; Minichromosome maintenance 8; Minichromosome main
Anti-MYOZ2 Polyclonal Antibody
Anti-MYOZ2 Polyclonal Antibody应用 WB 稀释比例 WB 1:5000-8000. 交叉反应 Human
Anti-CP110 Polyclonal Antibody
Anti-CP110 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human